CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells. - Kumar S; Zeng Z; Bagati A; Tay RE; Sanz LA; Hartono SR; Ito Y; Abderazzaq F; Hatchi E; Jiang P; Cartwright ANR; Olawoyin O; et al. (Cancer discovery, 2021)